Cologne, Germany

Andreas Scheidig

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 8.8

ph-index = 3

Forward Citations = 98(Granted Patents)


Location History:

  • Köln, DE (2008 - 2013)
  • Cologne, DE (2010 - 2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Contributions of Inventor Andreas Scheidig in Biotech Innovations

Introduction: Andreas Scheidig, a distinguished inventor based in Cologne, Germany, has made significant strides in the field of biotechnology. With a portfolio of four patents to his name, Scheidig's work primarily focuses on the development of antibodies that target tumor necrosis factor alpha (TNFα), a crucial aspect of therapeutic interventions in various diseases.

Latest Patents: Among his most recent patents are innovative antibodies that bind specifically to TNFα. These patents not only cover the antibodies themselves but also include antigen binding portions and derivatives thereof. In addition, they encompass nucleic acids encoding these antibodies, as well as vectors and host cells that contain the pertinent nucleic acids. This breakthrough has the potential to facilitate novel treatment strategies for conditions associated with TNFα.

Career Highlights: Scheidig has been instrumental in his professional journey, having worked with notable companies such as Direvo Biotechnology AG and Bayer Pharma Aktiengesellschaft. His expertise and innovative spirit have allowed him to contribute significantly to advancements in therapeutic antibody development.

Collaborations: Throughout his career, Scheidig has collaborated with esteemed colleagues, including Ulrich Haupts and Christian Votsmeier. These partnerships have fostered a collaborative environment conducive to research and innovation in the biotechnology sector.

Conclusion: Andreas Scheidig's work exemplifies the impact of innovative thinking in biotechnology. With his remarkable contributions to antibody development, he continues to pave the way for future advancements in medical therapies. His patents not only underscore his ingenuity but also reflect the collaborative efforts that drive progress in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…